Security key
740459102
Picard Medical, Inc. - Common Stock, $0.0001 par value per share
CUSIP: 740459102
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 1
- Total 13F value
- $53
- Share change
- 0
- SEC-reported price per share
- $53.00
- Number of holders
- 1
- Shares outstanding
- 73,551,713
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
1
Top holders
1
740459102 full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
Picard Medical, Inc. SEC filings
Picard Medical, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 740459102
Recent filing periods:
Ownership snapshot
Top reported holders of 740459102 - Picard Medical, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VERSA CAPITAL FUND III, L.P.
Disclosed value leader
Aristides Capital LLC
Comparable rows
1/15
Latest evidence
31 Dec 2025
13D/G
3/4/5
13F
Lead comparable stake: 11%
14 rows are not safely comparable across share classes.
13D/G row: VERSA CAPITAL FUND III, L.P.
Showing 1-6 of 15 holder rows.
Quick read
VERSA CAPITAL FUND III, L.P. leads the comparable SEC ownership view at 11%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VERSA CAPITAL FUND III, L.P.'s linked filing trail.
Comparable ownership
Top 1
VERSA CAPITAL FUND III, L.P.
11%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VERSA CAPITAL FUND III, L.P. |
13D/G
Sindex SSI Lending, LLC
|
11%
Reported 13D/G
· 11 Aug 2025
|
—
7,943,585 shares
|
$0 | 11 Aug 2025 |
| Sindex SSI Lending, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
7,943,585 shares
|
— | 11 Aug 2025 |
| Aristides Capital LLC |
13F
Company
|
—
denominator unverified
|
$117,796
67,312 shares
|
— | 31 Dec 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$102,752
58,716 shares
|
— | 31 Dec 2025 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$57,513
32,864 shares
|
— | 31 Dec 2025 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$50,946
29,112 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
1
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
1
Q1 2026 holders
1
Holder diff
0
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend